The Collaborative Study of Obesity and Diabetes in Adults (CODA) project: Meta-analysis design and description of participating studies

Obesity Reviews

Volumn 8, Issue 3, 2007, Pages 263-276

  Duval, S ^a   Vazquez, G ^a   Baker, W L ^a   Jacobs Jr , D R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Diabetes; Meta analysis; Obesity

Indexed keywords

ALCOHOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ALCOHOL CONSUMPTION; ANTHROPOMETRY; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DATA BASE; DIASTOLIC BLOOD PRESSURE; ETHNICITY; FAMILY HISTORY; HORMONE SUBSTITUTION; HUMAN; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; QUESTIONNAIRE; REVIEW; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE; WAIST HIP RATIO;

ABDOMINAL FAT; DIABETES MELLITUS, TYPE 2; HUMANS; META-ANALYSIS; OBESITY; PRIMARY PREVENTION;

EID: 34247392494     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/j.1467-789X.2006.00263.x     Document Type: Review

References (60)

1. Seidell JC, Kahn HS, Williamson DF, Lissner L, Valdez R. Report from a Centers for Disease Control and Prevention workshop on use of adult anthropometry for public health and primary health care. Am J Clin Nutr 2001 73: 123 126.
2. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 1998 6: S51 S210.
3. World Health Organization. Obesity Preventing and Managing the Global Epidemic: Report of the WHO Consultation of Obesity. Geneva: World Health Organization, 1997.
4. Scottish Intercollegiate Guidelines Network. Obesity in Scotland: Integrating Prevention with Weight Management. Edinburgh: SIGN, 1996.
5. Glumer C, Vistisen D, Borch-Johnsen K, Colagiuri S, on behalf of the DETECT-2 collaboration. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 2006 29: 410 414.
6. Nakagami T, Qiao Q, Carstensen B, Nhr-Hansen C, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K, The DECODE-DECODA Study Group: Age, body mass index and Type 2 diabetes associations modified by ethnicity. Diabetologia 2003 46: 1063 1070.
7. DECODE Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003 26: 61 69.
8. The DECODA Study Group. Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003 26: 1770 1780.
9. Young TK, Harris SB. Risk of clinical diabetes in a Northern Native Canadian cohort. Arctic Med Res 1994 53: 64 70.
10. Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF. Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 1997 46: 701 710.
11. Chen KT, Chen CJ, Gregg EW, Imperatore G, Narayan KMV. Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years. Diabetes Res Clin Pract 2003 60: 177 182.
12. Shin CS, Yoo KY, Lee HK, Paik HY, Koh C-S, Park YS, Kim YI, Yang BG, Shin YS. Risk factors for the development of NIDDM in Yonchon County, Korea. Diabetes Care 1997 20: 1842 1846.
13. Boyko EJ, Chitson P, de Courten M, Tuomilehto J, Zimmet PZ, Alberti KGMM. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance. A prospective study of Mauritius. Diabetes Care 2000 23: 1242 1248.
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26: 3160 3167.
15. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999.
16. Wang J, Thornton JC, Bari S, Williamson B, Gallagher D, Heymsfield SB, Horlick M, Kotler D, Laferrere B, Mayer L, Pi-Sunyer FX, Pierson RN Jr. Comparisons of waist circumferences measured at 4 sites. Am J Clin Nutr 2003 77: 379 384.
17. Bennett DA. Review of analytical methods for prospective cohort studies using time to event data: single studies and implications for meta-analysis. Stat Methods Med Res 2003 12: 297 319.
18. Higgins JPT, Whitehead A, Turner RM, Omar RZ, Thompson SG. Meta-analysis of continuous outcome data from individual patients. Stat Med 2001 20: 2219 2241.
19. Whitehead A, Omar RZ, Higgins JPT, Savaluny E, Turner RM, Thompson SG. Meta-analysis of ordinal outcomes using individual patient data. Stat Med 2001 20: 2243 2260.
20. Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials 2005 2: 209 217.
21. Thompson SG, Turner RM, Warn DE. Multilevel models for meta-analysis, and their application to absolute risk differences. Stat Methods Med Res 2001 10: 375 392.
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986 7: 177 188.
23. Normand S.L.T. Meta-analysis. formulating, evaluating combining and reporting. Stat Med 1999 18: 321 359.
24. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 1998 21: 1559 1573.
25. Dunstan DW, Zimmet PZ, Welborn TA, Cameron AJ, Shaw J, de Courten M, Jolley D, McCarty DJ, AusDiab Steering Committee. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates. Diabetes Res Clin Pract 2002 57: 119 129.
26. Castell C, Tresserras R, Serra J, Goday A, Lloveras G, Salleras L. Prevalence of diabetes in Catalonia (Spain): an oral glucose tolerance test-based population study. Diabetes Res Clin Pract 1999 43: 33 40.
27. Mohan V, Shanthirani S, Deepa R, Premalatha G, Sastry NG, Saroja R. Intra-urban differences in the prevaence of the metabolic syndrome in southern India - the Chennai Urban Population Study (CUPS No. 4). Diabetic Medicine 2001 18: 280 287.
28. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, Mohan V. The Chennai Urban Rural Epidemiology Study (CURES) - study design and methodology (urban component) (CURES-I). J Assoc Physicians India 2003 51: 863 870.
29. Amoah AGB. Undiagnosed diabetes and impaired glucose regulation in adult Ghanaians using the ADA and WHO diagnostic criteria. Acta Diabetol 2002 39: 7 13.
30. Ajlouni K, Jaddou H, Batieha A. Diabetes and impaired glucose tolerance in Jordan: prevalence and associated risk factors. J Intern Med 1998 244: 317 323.
31. Domarkiene S, Tamosiunas A, Reklaitiene R, Sidlauskiene D. Trends in main cardiovascular risk factors among middle-aged Kaunas population between 1983 and 2002. Medicina (Kaunas) 2003 39: 1193 1199.
32. Cottel D, Dallongeville J, Wagner A, Ruidavets JB, Arveiler D, Ferrieres J, Bingham A, Marecaux N, Ducimetiere P, Amouyel P. The North-East-South gradient of coronary heart disease mortality and case fatality rates in France is consistent with a similar gradient in risk factor clusters. European Journal of Epidemiology 2000 16: 317 322.
33. Okosun IS. Racial differences in rates of Type 2 diabetes in American women: how much is due to differences in overall adiposity? Ethn Health 2001 6: 27 34.
34. Ramachandran A, Snehalatha C, Kapur A, Vijay V, Mohan V, Das AK, Rao PV, Yajnik CS, Prasanna KM, Nair JD, for the Diabetes Epidemiology Study Group in India (DESI). High prevalence of diabetes and impaired glucose tolerance in India: national urban diabetes survey. Diabetologia 2001 44: 1094 1101.
35. Dennis BH, Pajak A, Pardo B, Davis CE, Williams OD, Piotrowski W. Weight gain and its correlates in Poland between 1983 and 1993. Int J Obes Relat Metab Disord 2000 24: 1507 1513.
36. Cutter J, Tan BY, Chew SK. Levels of cardiovascular disease risk factors in Singapore following a national intervention programme. Bull World Health Organ 2001 79: 908 915.
37. Chihaoui M, Kanoun F, Ben Rehaiem B, Ben Brahim S, Ftouhi B, Mekaouar A, Fekih M, Mbazaa A, Zouari B, Ben Khalifa F. Predictive risk factors for deterioration from normoglycemic state to type 2 diabetes mellitus or impaired glucose tolerance in a Tunisian urban population. Diabetes Metab 2001 27: 487 495.
38. Scragg R, Baker J, Metcalf P, Dryson E. Prevalence of diabetes mellitus and impaired glucose tolerance in a New Zealand multiracial workforce. N Z Med J 1991 104: 395 397.
39. Bjorkelund C, Bondyr-Carlsson D, Lapidus L, Lissner L, Mansson J, Skoog I, Bengtsson C. Sleep disturbances in midlife unrelated to 32-year diabetes incidence. The prospective population study of women in Gothenburg. Diabetes Care 2005 28: 2739 2744.
40. Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong C-P. Associations of general and abdominal obesity with multiple outcomes in older women. The Iowa Women's Health Study. Arch Intern Med 2000 160: 2117 2128.
41. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurse's Health Study. Am J Epidemiol 1997 145: 614 619.
42. ARIC investigators. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. Am J Epidemiol 1989 129: 687 702.
43. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR, Liu K, Savage PJ. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988 41: 1105 1116.
44. Williams DR, Wareham NJ, Brown DC, Byrne CD, Clark PM, Cox BD, Cox LJ, Day NE, Hales CN, Palmer CR. Undiagnosed glucose intolerance in the community: the Isle of Ely Diabetes Project. Diabet Med 1995 12: 30 35.
45. Tuomilehto J, Marti B, Kartovaara L, Korhonen HJ, Pietinen P. Body fat distribution, serum lipoproteins and blood pressure in middle-aged Finnish men and women. Rev Epidemiol Sante Publique 1990 38: 507 515.
46. Meigs JB, Wilson PWF, Nathan DM, D'Agostino RB Sr, Williams K, Haffner SM. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003 52: 2160 2167.
47. Ito C, Maeda R, Ishida S, Harada H, Inoue N, Sasaki H. Importance of OGTT for diagnosing diabetes mellitus based on prevalence and incidence of retinopathy. Diabetes Res Clin Pract 2000 49: 181 186.
48. Wagenknecht LE, Mayer EJ, Rewers M, Haffner S, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF. The Insulin Resistance Atherosclerosis Study (IRAS). Objectives, design, and recruitment results. Ann Epidemiol 1995 5: 464 472.
49. Boyko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY. Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men. Diabetes 1996 45: 1010 1015.
50. Gimeno SG, Ferreira SR, Franco LJ, Iunes M. Comparison of glucose tolerance categories according to World Health Organization and American Diabetes Association diagnostic criteria in a population-based study in Brazil. The Japanese-Brazilian Diabetes Study Group. Diabetes Care 1998 21: 1889 1892.
51. Haffner SM, Gonzalez C, Mykkanen L, Stern MP. Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study. Diabetologia 1997 40: 830 837.
52. Cassano PA, Rosner B, Vokonas PS, Weiss ST. Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus. A prospective cohort study of men in the Normative Aging Study. Am J Epidemiol 1992 136: 1474 1486.
53. Dowse GK, Zimmet PZ, Finch CF, Collins VR. Decline in incidence of epidemic glucose intolerance in Nauruans: implications for the 'thrifty genotype'. Am J Epidemiol 1991 133: 1093 1104.
54. Eliasson M, Asplund K, Nasic S, Rodu B. Influence of smoking and snus on the prevalence and incidence of type 2 diabetes amongst men: the northern Sweden MONICA study. J Intern Med 2004 256: 101 110.
55. Rajala U, Laakso M, Qiao Q, Keinanen-Kiukaanniemi S. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diabetes Care 1998 21: 1664 1669.
56. Balkau B, Forhan A, Eschwege E. Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study. Diabetologia 2002 45: 1224 1230.
57. Wedick NM, Mayer-Davis EJ, Wingard DL, Addy CL, Barrett-Connor E. Insulin resistance precedes weight loss in adults without diabetes: The Rancho Bernardo Study. Am J Epidemiol 2001 153: 1198 1205.
58. Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP. Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 1991 14: 102 108.
59. Lee ET, Welty TK, Fabsitz R, Cowan LD, Le N-A, Oopik AJ, Cucchiara AJ, Savage PJ, Howard BV. The Strong Heart Study. A study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990 132: 1141 1155.
60. Zethelius B, Byberg L, Hales CN, Lithell H, Berne C. Proinsulin is an independent predictor of coronary heart disease: report from a 27-year follow-up study. Circulation 2002 105: 2153 2158.